back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2015-08-17 Tx date 2015-08-15 |
$TTH
Transition Therapeutics Inc. |
Damiani, Carl
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants $6.50 Warrants
55 - Expiration of warrants
|
$-31,031
-4,774 vol $6.50 each |
0 | |
| Filed 2015-08-17 Tx date 2015-08-15 |
$TTH
Transition Therapeutics Inc. |
CRUZ, TONY
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants 6.50
55 - Expiration of warrants
|
$-124,104.50
-19,093 vol $6.50 each |
0 | |
| Filed 2015-08-17 Tx date 2015-08-15 |
$TTH
Transition Therapeutics Inc. |
CRUZ, TONY
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants 4.60
55 - Expiration of warrants
|
$-71,359.80
-15,513 vol $4.60 each |
0 | |
| Filed 2015-08-17 Tx date 2015-08-15 |
$TTH
Transition Therapeutics Inc. |
Pace, Gary W.
4 - Director of Issuer
Direct Ownership
|
Warrants 6.50
55 - Expiration of warrants
|
$-31,024.50
-4,773 vol $6.50 each |
0 | |
| Filed 2015-08-17 Tx date 2015-08-15 |
$TTH
Transition Therapeutics Inc. |
Pace, Gary W.
4 - Director of Issuer
Direct Ownership
|
Warrants 4.60
55 - Expiration of warrants
|
$-17,838.80
-3,878 vol $4.60 each |
0 | |
| Filed 2015-08-17 Tx date 2015-08-15 |
$TTH
Transition Therapeutics Inc. |
Damiani, Carl
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants $4.60 Warrants
55 - Expiration of warrants
|
$-17,843.40
-3,879 vol $4.60 each |
0 | |
| Filed 2015-08-14 Tx date 2015-08-12 |
$TTH
Transition Therapeutics Inc. |
CRUZ, TONY
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-192,500
-55,000 vol $3.50 each |
695,000 | |
| Filed 2015-08-14 Tx date 2015-08-12 |
$TTH
Transition Therapeutics Inc. |
Damiani, Carl
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-87,500
-25,000 vol $3.50 each |
325,000 | |
| Filed 2015-08-14 Tx date 2015-08-12 |
$TTH
Transition Therapeutics Inc. |
Pastrak, Aleksandra
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-140,000
-40,000 vol $3.50 each |
310,000 | |
| Filed 2015-08-14 Tx date 2015-08-12 |
$TTH
Transition Therapeutics Inc. |
Rusaw, Norla Nicole
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-52,500
-15,000 vol $3.50 each |
192,193 | |
| Filed 2015-07-14 Tx date 2015-07-10 |
$TTH
Transition Therapeutics Inc. |
Pace, Gary W.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-34,200
-10,000 vol $3.42 each |
75,000 | |
| Filed 2015-07-14 Tx date 2015-07-10 |
$TTH
Transition Therapeutics Inc. |
Baehr, Paul
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-34,200
-10,000 vol $3.42 each |
75,000 | |
| Filed 2015-07-14 Tx date 2015-07-10 |
$TTH
Transition Therapeutics Inc. |
Ashton, Michael R. D.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-34,200
-10,000 vol $3.42 each |
75,000 | |
| Filed 2015-07-14 Tx date 2015-07-10 |
$TTH
Transition Therapeutics Inc. |
Henley, Christopher
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-34,200
-10,000 vol $3.42 each |
75,000 | |
| Filed 2015-06-14 Tx date 2015-06-14 |
$TTH
Transition Therapeutics Inc. |
Ashton, Michael R. D.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$152,850
+15,000 vol $10.19 each |
85,000 | |
| Filed 2015-06-14 Tx date 2015-06-14 |
$TTH
Transition Therapeutics Inc. |
Pace, Gary W.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$152,850
+15,000 vol $10.19 each |
85,000 | |
| Filed 2015-06-14 Tx date 2015-06-14 |
$TTH
Transition Therapeutics Inc. |
Henley, Christopher
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$152,850
+15,000 vol $10.19 each |
85,000 | |
| Filed 2015-06-14 Tx date 2015-06-14 |
$TTH
Transition Therapeutics Inc. |
Baehr, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$152,850
+15,000 vol $10.19 each |
85,000 | |
| Filed 2015-06-09 Tx date 2008-07-03 |
$TTH
Transition Therapeutics Inc. |
Rusaw, Norla Nicole
5 - Senior Officer of Issuer
Holder: RESP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-09 Tx date 2015-06-09 |
$TTH
Transition Therapeutics Inc. |
Rusaw, Norla Nicole
5 - Senior Officer of Issuer
Holder: RESP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,000 vol |
1,000 | |
| Filed 2015-05-06 Tx date 2015-05-01 |
$TTH
Transition Therapeutics Inc. |
Abushakra, Sawsan
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,900 vol |
30,898 |